Evidence map›Paper›PMID 40999330›Full record

ArticleBMC infectious diseases2025

Phylogenetics and selective pressure analysis of human papillomavirus types 31 and 33 variants in Eastern China.

Yan Wang, Wenjie Qu, Qi Zhou, Yingxin Gong, Yaping Wang, Fang Chen, Jiayin Mo, Lin Lin, Tianyi Bi, Wenqian Shi and 7 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yan Wang *Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Wenjie Qu *Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Qi Zhou *Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Yingxin GongShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Yaping WangShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Fang ChenShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Jiayin MoShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Lin LinShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Tianyi BiShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Wenqian ShiShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Feifei ZhangShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Zhiyong WuShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China.
Yu SunSchool of Public Health, Fudan University, Shanghai, China.
Xing LiuSchool of Public Health, Fudan University, Shanghai, China.
Na HeSchool of Public Health, Fudan University, Shanghai, China. nhe@fudan.edu.cn.
Yanyun LiShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China. liyanyun@fudan.edu.cn.
Congjian XuShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China. xucongjian@fudan.edu.cn.

Funding

National Key Research and Development Program of China 2022YFC2407406National Natural Science Foundation of China 82272970 ,82472628Qingpu District Health Commission MY2023-3, MY2023-5Science and Technology Commission of Shanghai Municipality 21Y11906500Shanghai Municipal Health Commission GWVI-11.2-XD13
6 · The paper itself

Abstract

objectivesThe aim of this study is to identify the distribution of HPV31 and HPV33 lineages and sublineages, characterize their genetic variability, explore associations between cervical lesions, persistent/multiple infections, and HPV31/33 genetic variations, and estimate selective pressures and divergence times for both genotypes.

methodsIn this study, a total of 94 samples were collected, with 276 full-length gene sequences obtained for analysis. Phylogenetic analysis evaluating genetic variant diversity was performed using MEGA software. Correlation analyses were conducted using SPSS 20.0. Selective pressure and divergence time estimations were performed using the Datamonkey web server and BEAST v1.8.3, respectively.

resultsLineage A, B, and C variants were identified in 26.1%, 4.3%, and 69.6% of the HPV31 isolates, respectively, whereas all the HPV33 variants belonged to lineage A. We detected 108 nucleotide variations in HPV31 and 126 in HPV33. For HPV33, the nonsynonymous mutation A862T (Q97L) in the E7 gene was significantly correlated with cervical lesions (χ

conclusionOur study revealed two substitutions-A862T (Q97L) and G7064A (S491S)-associated with cervical lesions, along with eleven sites under positive selection. This work provides new insights into the clinical characteristics of HPV31/33 genetic variations and offers novel perspectives for developing next-generation vaccines in Eastern China.

Indexed as

Genetic VariationHuman papillomavirus 31PapillomaviridaePapillomavirus InfectionsPhylogenySelection, GeneticAdultChinaFemaleGenotypeHuman Papillomavirus VirusesHumansMiddle AgedYoung AdultEastern ChinaHuman papillomavirus 31 and 33Phylogenetics analysisSelective pressure

Identifiers

PMID40999330
PMCPMC12465174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.